Pterine-6-carboxylic acid

CAS No. 948-60-7

Pterine-6-carboxylic acid( —— )

Catalog No. M37805 CAS No. 948-60-7

Pterine-6-carboxylic acid (6-Carboxypterin) is a photodegradation product of folic acid, which can be used as a photosensitive agent to study the molecular mechanism of UVA breaking DNA structure.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 66 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pterine-6-carboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Pterine-6-carboxylic acid (6-Carboxypterin) is a photodegradation product of folic acid, which can be used as a photosensitive agent to study the molecular mechanism of UVA breaking DNA structure.
  • Description
    Pterin-6-carboxylic acid serves as a precursor for the formation of folate, which plays a critical role in cell growth, development, and repair. Pterine-6-carboxylic acid has been studied for its potential as a fluorescent dye.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE | DNA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    948-60-7
  • Formula Weight
    207.15
  • Molecular Formula
    C7H5N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Nc1nc2ncc(nc2c(=O)[nH]1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Oluwasegun Modupe, et al. A spectrophotometric method for determining the amount of folic acid in fortified salt. J Agric Food Res. 2020 Dec:2:100060.
molnova catalog
related products
  • Dypyridamole

    Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.

  • Triflusal

    Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.

  • PF-04957325

    PF-04957325 is a potent and selective inhibitor of PDE8.PF-04957325 has an IC50 of 0.7 nM for PDE8A and 0.3 nM for PDE8B.PF-04957325 can be used to study autoimmune encephalomyelitis.